3',5'-dichloromethotrexate has been researched along with Benign Neoplasms in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| VOGEL, AW | 1 |
| Fernbach, B; Holland, JF; Ohnuma, T; Takahashi, I | 1 |
| Donehower, RC; Ettinger, DS; Grochow, LB; Hantel, A; McGuire, WP; Noe, DA; Rowinsky, EK; Vito, BL | 1 |
| Alonso, MT; Eisenberger, M; Hoth, DF; Leyland-Jones, B; O'Dwyer, PJ | 1 |
4 other study(ies) available for 3',5'-dichloromethotrexate and Benign Neoplasms
| Article | Year |
|---|---|
Tumor and marrow damage occurring from methotrexate, monofluoromethotrexate, difluoromethotrexate, and dichloromethotrexate.
Topics: Animals; Bone Marrow; Folic Acid Antagonists; Humans; Methotrexate; Neoplasms; Neoplasms, Experimental; Vegetables | 1961 |
Clinical and laboratory reevalution of dichloromethotrexate.
Topics: Adult; Aged; Antineoplastic Agents; Female; Humans; Male; Methotrexate; Middle Aged; Neoplasms | 1980 |
Clinical and pharmacologic reappraisal of dichloromethotrexate.
Topics: Adult; Aged; Antineoplastic Agents; Bone Marrow; Dose-Response Relationship, Drug; Female; Humans; Liver; Male; Metabolic Clearance Rate; Methotrexate; Middle Aged; Neoplasms | 1988 |
Dichloromethotrexate--a critical reassessment.
Topics: Animals; Antineoplastic Agents; Drug Evaluation; Drug Evaluation, Preclinical; Folic Acid Antagonists; Humans; Infusions, Intra-Arterial; Kinetics; Methotrexate; Neoplasms; Neoplasms, Experimental | 1985 |